Phase I And Pharmacokinetic Study Of Osi-211, A Liposomal Formulation Of Lurtotecan, A Topoisomerase 1 Inhibitor, In Patients With Advanced Leukemia. F Giles,M Tallman, G Garcia-Manero, J Cortes, D Thomas,W Wierda, S Verstovsek,M Hamilton,E Barrett,M Albitar,H KantarjianBLOOD（2003）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
